Search Results 381-390 of 7737 for SC

  1. Contact us - Mayo Clinic

    SC: Mayo Clinic Breadcrumb. About Mayo Clinic · International Business Collaborations. Sections International Business Collaborations. Mayo Clinic Cardiology ...

  2. Contact us - Mayo Clinic

    SC: Mayo Clinic Breadcrumb. About Mayo Clinic · Mayo Clinic Care Network. Sections Mayo Clinic Care Network. Amplify expertise. Collapse Amplify expertise.

  3. Publications - Pablo Moreno Franco, M.D. - Mayo Clinic

    ... SC, Pollock BD. Exploring COVID-19 census burdens by US hospital characteristics: Implications of quality reporting at rural and critical access hospitals ...

  4. A Study to Evaluate the Effectiveness and Safety of Lanadelumab for Prevention Against Acute Attacks of Non-histaminergic Angioedema in Adolescents and Adults - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of repeated subcutaneous (SC) administrations of Lanadelumab in preventing angioedema ...

  5. Naveen L. Pereira, M.D. - Doctors and Medical Staff - Mayo Clinic

    MemberSouth Carolina Medical Association. 1998 - present. MemberMassachusetts Medical Society. 1998 - present. MemberInternational Society for Heart and Lung ...

  6. A Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... [SC] or intramuscular ... at least one 2-week induction regimen of golimumab (one 200 mg SC dose followed by one 100 mg SC dose at least 2 weeks apart); ...

  7. A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Depemokimab in Adults With Hypereosinophilic Syndrome (HES) - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness of depemokimab 200 mg subcutaneous (SC) given every 6 months versus placebo in participants with ...

  8. Bell's palsy - Symptoms and causes - Mayo Clinic

    Learn more about this condition that causes temporary facial paralysis. Find out why it happens and what to do about it.

  9. A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma - Mayo Clinic

    The primary objective of this study is to determine whether treatment with daratumumab administered subcutaneously (SC) prolongs progression-free survival ...

  10. Publications - Aaron J. Krych, M.D. - Mayo Clinic

    Meta F, Clark SC, Tagliero AJ, Hevesi M, Saris DBF, Krych AJ. Athlete-Specific Considerations of Cartilage Injuries. Sports Med Arthrosc Rev. 2024 Jun 1; 32 ...